GDNF protein Parkinson’s treatment ‘extremely promising’

A trial has found that an experimental drug called GDNF could offer hope for restoring damaged brain cells in Parkinson’s patients. Scientists said some brain scans revealed “extremely promising” effects on damaged neurons after the protein therapy was delivered directly into the brains of Parkinson’s patients. Glial Cell Line Derived Neurotrophic Factor (GDNF) is a […]

Continue Reading